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Abstract
Background: We hypothesized that genetic modification of mesenchymal stem cells (MSCs) with Sonic Hedgehog (Shh)
transgene, a morphogen during embryonic development and embryonic and adult stem cell growth, improved their
survival and angiogenic potential in the ischemic heart via iNOS/netrin/PKC pathway.
Methods/Principal Findings: MSCs from young Fisher-344 rat bone marrow were purified and transfected with pCMV Shh
plasmid (
ShhMSCs). Immunofluorescence, RT-PCR and Western blotting showed higher expression of Shh in
ShhMSCs which
also led to increased expression of angiogenic and pro-survival growth factors in
ShhMSCs. Significantly improved migration
and tube formation was seen in
ShhMSCs as compared to empty vector transfected MSCs (
EmpMSCs). Significant
upregulation of netrin-1 and iNOS was observed in
ShhMSCs in PI3K independent but PKC dependent manner. For in vivo
studies, acute myocardial infarction model was developed in Fisher-344 rats. The animals were grouped to receive 70 ml
basal DMEM without cells (group-1) or containing 1610
6 EmpMSCs (group-2) and
ShhMSCs (group-3). Group-4 received
recombinant netrin-1 protein injection into the infarcted heart. FISH and sry-quantification revealed improved survival of
ShhMSCs post engraftment. Histological studies combined with fluorescent microspheres showed increased density of
functionally competent blood vessels in group-3 and group-4. Echocardiography showed significantly preserved heart
function indices post engraftment with
ShhMSCs in group-3 animals.
Conclusions/Significance: Reprogramming of stem cells with Shh maximizes their survival and angiogenic potential in the
heart via iNOS/netrin-1/PKC signaling.
Citation: Ahmed RPH, Haider KH, Shujia J, Afzal MR, Ashraf M (2010) Sonic Hedgehog Gene Delivery to the Rodent Heart Promotes Angiogenesis via iNOS/Netrin-
1/PKC Pathway. PLoS ONE 5(1): e8576. doi:10.1371/journal.pone.0008576
Editor: Annarosa Leri, Harvard Medical School, United States of America
Received September 14, 2009; Accepted November 2, 2009; Published January 5, 2010
Copyright:  2010 Ahmed et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants #R37-HL074272; HL-080686; HL087246 to M.A. and HL087288; HL089535 to Kh.H.H.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: muhammad.ashraf@uc.edu
Introduction
Sonic hedgehog (Shh) gene is one of the highly conserved
mammalian hedgehog genes and has a wide distribution in a
variety of tissues during embryonic development [1]. The post-
natal intrinsic activity of Shh remains intact albeit with sub-
optimal functioning and is reactivated under tissue ischemia and in
various pathologies, including tumors [2,3]. Such post-natal
reactivation of the embryonic signaling pathways implying Shh
in response to muscle injury in the animal models incurred
enhanced angiomyogenic response [4,5]. In one of the experi-
mental studies, more than 15-fold increase in Shh mRNA
expression was observed in the ischemic myocardium [6]. An
outside intervention to overexpress Shh in the heart activated its
downstream signaling cascade and strongly induced Patched1
(Ptc1) expression in the cardiomyocytes which indicated an active
participation of Shh in the myocardial repair process. Interesting-
ly, activation of Shh signaling caused upregulation of pro-
angiogenic growth factors including vascular endothelial growth
factor (VEGF) and angiopoietin-1 which resulted in an increased
angiogenic response and globally improved the heart function.
Bone marrow derived stem cells (BMSCs) which have been
shown to improve heart function, attenuate infarct size expansion
and contribute to myocardial regeneration both in the experi-
mental as well as in clinical settings [7–10]. In addition, BMSCs
are excellent carriers of therapeutic genes to the heart [11–13]. In
the present study we took advantage of the anti-apoptotic and pro-
angiogenic role of Shh signaling and combined Shh transgene
delivery to the infarcted heart by transplantation of mesenchymal
stem cells (MSCs) which were non-virally transfected to overex-
press Shh. The anticipated objective of our multipronged strategy
was to achieve intracrine, autocrine, and paracrine effects of Shh
protein which was secreted from MSCs overexpressing Shh
(
ShhMSCs) and regenerated the damaged tissue, induced revascu-
larization and concomitantly prevented remodeling of the heart by
preserving the existing myocardium.
Treatment of the cells with Shh or instrinsic Shh gene
overexpression in response to various factors involve signaling
pathways including PI3K/Akt, Ras/ERK and PKC. PKC
participates as a mediator of signal transduction during multiple
cellular responses to cellular signals which stimulate cell prolifer-
ation, and differentiation. Our results showed that Shh transgene
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8576over expression in MSCs initiated PKC signaling which was
characterized by the activation of PKM, a catalytic fragment of
PKC.
ShhMSCs showed better survival post-engraftment as
compared with the empty vector transfected control MSCs
(
EmpMSCs). Moreover, we report that Shh upregulated angiogenic
genes such as netrin-1, iNOS, VEGF and angiopoietins, which
play a significant role in Shh induced angiogenesis. Shh-induced
upregulation of netrin-1 and iNOS was PKC dependent. We
further observed that PKM was upregulated in
ShhMSCs and was
sensitive to cyclopamine and chel pretreatment of the cells.
Materials and Methods
Detailed methods are available in Text S1. Table S1 shows the
antibodies used for immunohistology and Western blotting, and
Table S2 shows the primers used for RT-PCR. Young female
Fischer-344 rats (n=30) each weighing 180–200 g were used in
this study. The present study conformed to the Guide for the Care
and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised 1996)
and protocol approved by the Institutional Animal Care and Use
Committee, University of Cincinnati. All surgical manipulations
were carried out under general anesthesia.
Results
In vitro Studies
Shh plasmid was successfully constructed using commercially
available pCMV Script Vector using mRNA isolated from 14-day
rat embryo and the plasmid construct was sequenced for correct
insertion of Shh transgene (Figure S1A & Figure S1B). RT-PCR
and Western blotting revealed significantly elevated expression of
Shh gene (12-fold) and protein (4.5-fold) in
ShhMSCs as compared
with
EmpMSCs (Figure 1A & 1B). Fluorescent immunostaining
showed that more than 65% cells stained positive for Shh
transgene overexpression (Figure 1C). At 72-h after transfection
with Shh, Ptc1 gene expression was 2.7-fold higher in
ShhMSCs as
compared with
EmpMSCs. These findings were confirmed by
Western blot (Figure 1D) and fluorescent immunostaining
(Figure 1E). Flow cytometry showed that Shh overexpression did
not alter surface marker expression in
ShhMSCs (Figure S1C).
Shh Induced Angiogenic Growth Factor Expression in
MSCs
In addition to upregulation of Ptc1, overexpression of Shh in
MSCs stimulated the expression of secretable angiogenic growth
factors including Ang-1 and VEGF. Our custom-made real-time
PCR based array of 72 genes revealed multiple angiogenic growth
factorsshowingmore than2-foldincreaseascomparedto
EmpMSCs
(Table S3). Western blot studies using cell lysate protein samples
from
ShhMSCs and
EmpMSCs confirmed these findings (Figure 2A).
Shh Caused Endothelial Mobilization and Tube
Formation
We investigated the ability of human umbilical vein endothelial
cells (HUVECs) to migrate toward conditioned medium from
ShhMSCs (
ShhCM) using a modified Boyden chamber assay
(Figure 2B). Incubation of HUVECs with
ShhCM for 4-h stimulated




ShhCM was determined by tube formation assay on matrigel
which showedthat morphological changes weremostobvious at 6-h
after incubation of the cells with
ShhCM as compared with
conditioned mediumfrom emptyvectortransfected MSCs(
EmpCM)
(Figure 2C). Quantification of the number of branch points per low
Figure 1. In vitro characterization of
ShhMSCs. (A) RT-PCR and (B) Western blotting showed significant amplification of Shh transgene and Shh
protein expression in
ShhMSCs as compared with
EmpMSCs on 72-h after transfection. (C) Fluorescent immunostaining of
ShhMSCs for Shh
overexpression (red fluorescence) at 72-h after trasnfection of Shh plasmid (magnification=100x). (D) Western blot and (E) Fluorescent
immunostaining revealed elevated expression of Ptc-1 in
ShhMSCs (green fluorescence) as compared with
EmpMSCs (magnification=100x).
doi:10.1371/journal.pone.0008576.g001
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structures were higher in
ShhCM as compared to the cells treated
with
EmpCM (p,0.01), and 10% FBS supplemented DMEM
(p,0.001) (Figure 2D). The formation of tubular structures was
abolished by prior treatment of the cells with anti-Shh (p,0.01 vs
shhCM without anti Shh antibody) and anti Netrin-1 antibodies
(p,0.01 vs
shhCM without anti-Shh antibody). Basal DMEM
without FBS supplementation failed to induce any morphological
changes in terms of tube formation (Figure 2D).
Shh Overexpression and Molecular Signaling in MSCs
iNOS gene expression was significantly increased in
ShhMSCs as
compared to
EmpMSCs (Figure 3A) which was confirmed by
Western blot (Figure 3B). Measurement of NO activity by using a
colorimetric NO assay kit showed that Shh overexpression was
associated with a concomitant increase in NO production in
ShhMSCs (Figure 3C). For every 100 mg protein, the amount of
NO produced in 100-min was 15 mmoles in
EmpMSCs and was
60 mmoles for
ShhMSCs. These results showed that iNOS
expression in
ShhMSCs was biologically active and contributed
to the production of NO.
Next we investigated whether PI3-kinase/Akt pathway was
involved in Shh-induced effects in MSCs. PI3K gene was
successfully knocked down in MSCs by transfection with PI3K
siRNA as compared to scrambled siRNA (Sc siRNA) transfected
cells which was indicated by abrogation of pAkt expression (Figure
S2). During Western blot studies, subsequent Shh transfection of
the respective siRNA transfected cells showed that PI3K/Akt
abrogation failed to block Shh induced iNOS expression
(Figure 3D; lane-3). On the contrary, treatment of MSCs with
Figure 2. Expression of secretable angio-competent growth factors from
ShhMSCs. A. Shh overexpression in MSCs induced significant
overexpression of multiple factors including Ang-1, VEGF, netrin-1 and iNOS as compared with
EmpMSCs. (B) Invasion assay showing significantly
higher migration of HUVECs in response to
ShhCM as compared with
EmpCM. (C) Culture of HUVECs in
ShhCM promoted their differentiation into
tubular network structures in vitro. Representative photomicrographs of HUVEC cultures for some experimental conditions as labeled in the
individual photomicrograph (Magnification=200x). (D) Quantitative analysis of network formation (formation of vascular assembly in culture) under
the different experimental conditions expressed as network projections per low-power field. Results are the mean6SE from triplicate samples.
doi:10.1371/journal.pone.0008576.g002
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significantly abolished iNOS expression in
ShhMSCs (Figure 3D).
We also found that Shh overexpression also induced panPKC
fragment PKM (45 kd; a proteolytic subunit of PKC) in
ShhMSCs
which was completely abolished by pretreatment of the cells with
2.5 mM chel or 1 mM cyclopamine (Figure 3E). Prolonged
activation of PKC can result in its proteolysis to the constitutively
active catalytic fragment protein kinase-M, which would dissociate
from the sarcolemma and phosphorylates proteins such as myosin
that are inaccessible to membrane-bound protein kinase-C. PKM
Figure 3.
ShhMSCs upregulated iNOS and netrin-1 expression. (A) RT-PCR and (B) Western blot showing significantly higher level iNOS gene
and protein expression respectively in
ShhMSCs as compared with
EmpMSCs. (C) iNOS activity assay showed increased NO production (in 100-min/
100 mg protein) in
ShhMSCs as compared with
EmpMSCs. This result was in accordance with higher level expression of iNOS in
ShhMSCs thus indicating
its functionally active status. (D) Transfection of
ShhMSCs with Sc siRNA and PI3K specific siRNA failed to abrogate iNOS expression. On the other hand,
pretreatment of
ShhMSCs with 2.5 mM chel or 1 mM cyclopamine significantly blocked iNOS expression in
ShhMSCs. (E) Western blot and densitometry
of changes in PKM expression in
ShhMSCs showed significantly higher level expression of 45 kDa fragment of PKC (PKM) in
ShhMSCs as compared to
EmpMSCs which was not blocked by PI3K specific RNA interference using Sc siRNA as a control. However, PKM fraction was sensitive to 2.5 mM chel or
1 mM cyclopamine. (F) Western blot showing significantly higher level protein expression of netrin-1 in
ShhMSCs (Lanes-2 & 3) as compared with
EmpMSCs (Lane-1). Netrin-1 expression was not abrogated by transfection of
ShhMSCs with PI3K siRNA or Sc siRNA (Lanes-2 & 3). However, netrin-1
expression in
ShhMSCs was abrogated by pretreatment of
ShhMSCs with 2.5 mM chel (Lane-4) or 1 mM cyclopamine (Lane-5).
doi:10.1371/journal.pone.0008576.g003
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maximal Ca
2+ concentrations [14]. However, PI3K specific RNA
interference failed to abolish PKM (Figure 3E).
Shh Upregulated Netrin-1 and iNOS Expression
Real-time PCR showed more than 60-fold increase in netrin-1
mRNA levels (Table S3). Western blot showed higher level of
netrin-1 in
ShhMSCs as compared to
EmpMSCs and similar to
iNOS expression, pretreatment of
ShhMSCs with 2.5 mM chel and
1 mM cyclopamine significantly abolished netrin-1 expression
(Figure 3F). These results indicated that PKC was essential for
Shh mediated upregulation of both iNOS and netrin-1.
ShhCM Improved Cell Survival
Using release of LDH as an indicator of cellular injury, LDH
release assay showed that treatment of native MSCs (Figure S3)
and H9C2 cardiomyocytes (Figure S4) with
ShhCM was cytopro-
tective and prevented cell death under oxidant stress.
In vivo Studies
Myocardial infarction model was developed in female Fisher-
344 rats by permanent ligation of the coronary artery. Trans-
plantation of the cells was carried out 10 days after the
development of myocardial infarction model in order to allow
local inflammatory response to subside in the infarcted heart. All
animals survived full length of studies and there were no deaths
related with cell transplantation. Four animals/group were
harvested for molecular studies on day-4 after their respective
treatment. Real-time PCR for sry-gene showed that the trans-
planted male donor cells survived significantly higher in
ShhMSCs
transplanted animal hearts (group-3) as compared with
EmpMSCs
transplanted animal hearts (group-2; p,0.01) (Figure 4). No sry-
gene signals were observed in basal DMEM injected animal hearts
(group-1) which served as a negative control. The presence of
surviving male donor
ShhMSCs were visualized by FISH staining
using fluorescently labeled rat y-chromosome specific probe
(Figure 4B).
ShhMSCs Attenuated Infarction Size and Enhanced
Angiogenic Potential
Eight weeks after their respective treatment, infarction size was
attenuated in group-2 and group-3 as compared with group-1
(n=4 per group). However, only group-3 showed significant
attenuation of infarction size (2363.9%) in comparison with
group-1 (45.562.8%; p=0.01) and group-2 (3664.01%; p,0.05)
(Figure 5). The vascular structures in the infarcted myocardium
(n=4 per group) were visualized by fluorescence immunostaining
specific for von Willebrand Factor-VIII (vWFactor-VIII) which
showed significantly higher blood vessel density (number of
capillaries/0.74 mm
2) in both infarct and peri-infarct regions in
group-3 in comparison with group-1 and group-2 (Figure 6A-B).
Capillary density in group-3 was 7467 and 114615 in the infarct
and peri-infarct areas respectively as compared to group-2
(6068.8 p=0.2 and 7068.6; p=0.002) and group-1 (21.561.5;
p,0.001 and 50.764.7; p,0.001). Between group-3 and group-2,
blood vessel density changed insignificantly in the infarct region
(p=0.2) but the change was significant in the peri-infarct region
(p=0.002). Counter immunostaining with anti-vascular smooth
muscle actin for arteriolar density (the number of arterioles/
0.74 mm
2) analysis showed higher blood vessel maturation
(staining positively for both vWF-VIII and vascular smooth
muscle actin) in group-3 (Figure 6A–B). The percentage of mature
blood vessels in infarct and peri-infarct areas was 88.866.1 and
96.560.7 in group-3 as compared to 85.464.6 and 9161i n
group-2 and 87.264.4 and 92.661.2 in group-1 (Figure 6C).
Although the percentage of the mature blood vessels did not show
any significant difference between the three treatment groups, the
total number of mature blood vessels was highest in group-3, thus
indicating a progressive maturation of the newly formed capillary
network in the presence of Shh overexpression. Vascular
diameters were also different between the three groups in the
infarct (Figure 6D) and peri-infarct (Figure 6E) areas. Setting up
the number of pixels as arbitrary units to determine blood vessel
diameter, the percentage of blood vessels with ,100 pixels was
significantly smaller in group-2 in both infarct (18.7%) and peri-
infarct (16.1%) areas as compared with infarct (31.9%) and peri-
infarct (34.8%) in group-3 (Figure 6D). On the other hand, the
percentage of medium sized blood vessels showed insignificant
difference in infarct areas of group-2 (43.7%) and group-3 (45.7%)
(Figure 6E). In total, (sum of blood vessels in infarct and peri-
infarct areas) blood vessels with a diameter ranging from ,100
pixels (33%), 100–200 pixels (39%) and .200 pixels (27%) were
observed in group-3 as compared with group-2 ,100 (17%),
Figure 4.
ShhMSCs survival in the infarcted heart. (A) Real-time
PCR for sry-gene showed improved survival of
ShhMSCs in the infarcted
rat heart on day-7 post engraftment as compared with
EmpMSCs. Basal
DMEM injected animal hearts showed no detection of sry-gene
expression and served as a negative control. (B) FISH using rat y-
chromosome specific probe labeled with red fluorescence to visualize
transplanted male
ShhMSCs on day-7 post-engraftment in group-3.
doi:10.1371/journal.pone.0008576.g004
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ShhMSCs were more efficient in induction of mature and medium
sized blood vessels as compared with
EmpMSCs. More important-
ly, despite extensive neovascularization observed in our experi-
ments, we did not witness the formation of hemangioma-like
structures subsequent to engraftment of
ShhMSCs. Structure
elucidation by hematoxylin/eosin staining revealed extensive
neovascularization with peculiar vascular lacunae filled with red
blood cells both in the infarct and peri-infarct regions (Figure 6F).
Similar angiogenic response in the infarcted heart was achieved by
injection of recombinant netrin-1. Capillary density at 40x
magnification (0.74 mm
2) in recombinant netrin-1 treated animal
hearts (group-4) was 6065.9 in infarct and 96.6623.3 in peri-
infarct areas which was significantly higher as compared with
group-1 in the infarct (p=0.002) and peri-infarct areas (p,0.001)
(Figure 7A). Similarly, arteriolar density was also higher in
recombinant netrin-1 treated animal hearts (group-4) in the
infarct and peri-infarct areas was 37.563.1 and 72.563 in group-
4 respectively as compared with group-1 (p,0.05) and group-2
(p,0.05) (Figure 7B).
ShhMSCs Improved Regional Blood Flow in the Infarcted
Heart
To investigate whether vascular density in the infarct and peri-
infarct regions were paralleled by increased regional blood flow,
myocardial perfusion analysis was performed using fluorescent
microspheres (n=3 per group; Figure 7C). Blood perfusion in the
infarcted myocardium was restored after implantation of
ShhMSCs
(group-3) in comparison with DMEM injected animals (group-1).
The average blood flow quantified in the infarcted heart in group-
3 was 0.0160.001 ml/mg/min which was significantly improved
as compared to group-1 0.0002 ml/mg/min. Although this
represented a significant 100-fold increase in the myocardial
regional blood flow in comparison with group-1, this increase in
group-3 was insignificant as compared with the normal heart
(0.0260.001 ml/mg/min).
ShhMSCs Improved Heart Function
Assessment of LV contractile and remodeling indices was
performed on day-7 after myocardial infarction (one day prior to
cell transplantation) and 8 weeks after cell transplantation (n=7
per group). Echocardiography showed deterioration of indices of
LV contractile function in all the three groups at 7-days after
myocardial infarction without any significant difference (p.0.05
between all the groups) (Figure 8). Thus, at 7-days post-infarction,
LV ejection fraction (LVEF) and LV fractional shortening (LVFS)
in group-1 were (41.962.55% and 16.361.1), group-2
(42.364.4% and 16.761.8) and group-3 (43.962.2% and
18.360.8) as compared with the baseline (67.363.4 and 4263)
respectively. At 8-weeks after their respective treatment, we
observed significantly deteriorated LVEF (35.862.3%) and LVFS
(13.861.17%) in group-1 (Figure 8A). On the contrary, there was
significant attenuation of LVEF and LVFS in group-2
(44.161.2%; 17.660.6%) and group-3 (52.364.4%; 21.861.2%)
as compared to the corresponding values of baseline echocardi-
ography (67.363.4%; 21.861.2%). As a marker of LV remodel-
ing, LV end diastolic diameter (LVEDD) and LV end systolic
diameter (LVESD), anterior wall thickness and posterior wall
thickness were assessed as shown in Table S4. Echocardiography
performed before and after their respective treatment in the
experimental and control groups clearly demonstrated that
intramyocardial administration of
ShhMSCs had favorable impact
on preservation of LV function in rats with chronic myocardial
infarction.
Discussion
We have shown that in vitro reprogramming of MSCs
maximizes their survival and angiogenic potential in the infarcted
heart. The salient findings of the study are: 1- Genetic
modification of MSCs with Shh transgene results in multifold
increased iNOS upregulation and NO production, an effect which
was associated with higher level of angiogenic growth factor
expression including VEGF, Ang-1 and netrin-1. 2- The induction
of iNOS in
ShhMSCs occurred in PKC dependent manner. 3-
ShhCM mediated increased angiogenic response was abrogated in
the presence of Shh and netrin-1 specific antibodies. 4-
Intramyocardial engraftment of
ShhMSC induced significant
angiogenesis, improved regional blood flow and significantly
preserved global heart function. We propose that the increased
angiogenesis is due to the production of NO with simultaneous
upregulation of multiple angio-competent factors including netrin-
1. The results from the present study also indicated that genetically
engineered
ShhMSCs promoted migration of endothelial progen-
itor cells which may be attributed to the dramatic upregulation of
MMP-9 (4-fold) in
ShhMSCs.
Sonic hedgehog (Shh) together with Desert hedgehog (Dhh) and
Indian hedgehog (Ihh) are three members of the hedgehog gene
family identified in the mammals [15]. Hedgehog signaling involves
binding of hedgehog with its ptch-1 receptor which in turn releases
itsinhibitoryeffectonSmoothened(smo).Activatedsmotheninitiates
signaling events which lead to regulation of transcriptional factors
belonging to the Gli family and its relevant downstream genes [16].
Shh is a secretary protein and therefore Shh gene delivery has been
assessed in experimental animal models of the infarcted heart [6].
Results from these studies indicate that postnatal reconstitution of
Shh signaling resulted in tissue preservation and repair, and that
gene therapy with Shh not only prevented fibrosis, it also promoted
angiogenesis and regional blood flow. Enhanced angiogenesis may
be attributed to the multiple effects of localized Shh transgene
expression. Activation of Shh pathway upregulates the expression of
Figure 5. Shh overexpression attenuated infarction size
expansion. Masson’s trichome staining of formalin fixed paraffin
embedded of the histological sections from (A) group-1 (B) group-2 and
(C) group-3 animal hearts was carried out to visualize the area of
fibrosis. Infarction size was significantly attenuated in group-3 after
ShhMSCs engraftment as compared with groups-1 and 2.
doi:10.1371/journal.pone.0008576.g005
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ShhMSCs improved blood vessel density in the infarcted heart. (A–B) Blood vessel density analysis for myocardial angiogenesis at
8-weeks after respective treatment in different groups of animals. The histological sections were immunostained for vWFactor-VIII (red) and smooth
muscle actin (green) for visualization of blood vessels. The number of blood vessels per surface area (0.74 mm
2) was significantly higher in the infarct
and peri-infarct areas in group-3 (p,0.05) as compared with group-1 and group-2. (C) The percentage of mature blood vessels (indicated by double
fluorescent immunostaining for vWFactor-VIII and smooth muscle actin) showed no significant difference between the three treatment groups.
However, (D–E) showed that average size of blood vessel diameter (based on number of pixels as arbitrary unit) was more uniform in peri-infarct
region of group-3. Blood vessels in the infarct and peri-infarct areas with diameter of ,100 pixels (33%), 100–200 pixels (39%) and .200 pixels (27%)
diameter was observed in group-3 as compared with group-2 ,100 (17%), 100–200 (43%) and .200 (39%). (F) Photomicrographs of hematoxylin-
eosin stained histological sections at 8-weeks after their respective treatment in group-3 and group-2. Red blood cells could be seen in some of the
blood vessels as indicated by green arrows showing the functional status of the blood vessels.
doi:10.1371/journal.pone.0008576.g006
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SDF-1a and IGF-1 and development of capillary network [4,17].
Our results were in harmony with these data and further showed
uniquely that Shh gene overexpression up-regulated iNOS, netrin-1
and HGF in addition to the already reported cytokines. HGF is a
mitogen of mesenchymal origin, and is also reported to stimulate
NO production and endothelial cell motility through upregulation
of iNOS [18]. Put together, these molecular changes lead to a
significant increase in biologically active NO production in
ShhMSCs.
iNOS is expressed following inflammatory or growth factor
stimulation of cells unlike its counterpart eNOS (endothelial nitric
oxide synthase) and nNOS (neuronal nitric oxide synthase) which
are constitutively expressed. Activation of iNOS can produce
copious amounts of NO for longer duration [19]. Generated from
the NOS enzyme activity, NO is recognized as an important
regulator of cardiovascular system functionality. Whereas NO
inhibits proliferation of smooth muscle cells, gene delivery of iNOS
to endothelial cells is protective for the cells via NO release without
an influence on their proliferation [20]. Secondly, endothelial cell
migration is an essential component of several vascular processes
includingthemaintenanceofendothelialintegrityandangiogenesis.
It is suggested that endothelial cells must exhibit a phenotype of
non-directional motility as a prerequisite for responding to stimuli
formigration.Thesamestudyproposesthat NOplaysanobligatory
role in elicitingthis phenotype. More recent studies have shown that
NO generated from iNOS activity modulates the expression of
matrix metalloproteinase-9 (MMP-9), an enzyme responsible for
degradation of extracellular matrix, which significantly influenced
cell migration [21]. A few previous studies have reported increased
MMP-9 the Shh-expressing cells, which was attenuated by the
inhibition of EGF receptor activation or blocking the EGF receptor
Figure 7. Recombinant netrin-1 treatment improved blood vessel density in the infarcted heart. (A) At 8-weeks after recombinant netrin-
1 delivery to the heart (group-4), the number of blood vessels per surface area (0.74 mm
2) was significantly higher as compared with group-1 in both
infarct as well as peri-infarct regions. (B) Double fluorescent immunostaining for vWFactor-VIII (red) and smooth muscle actin (green) showed that like
Shh overexpression in the heart, netrin-1 protein delivery resulted in increased arteriolar density (blood vessels double positive for vWFactor-VIII and
smooth muscle actin) in group-4. (C) Functional status of blood vessels in the infarcted heart was determined by fluorescent microsphere method for
regional blood flow studies assessment. Regional blood flow was significantly improved in group-3 animal hearts as compared with group-1.
However, regional blood flow changed insignificantly as compared with that of normal un-infarcted heart.
doi:10.1371/journal.pone.0008576.g007
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directly stimulate EGFR signaling. In the present study, prior
treatment of cells with cyclopamine and chel abrogated the
expression of iNOS and angiogenic growth factors including
VEGF, Ang-1 and netrin-1 thus suggesting that these pro-
angiogenesis relevant molecular events were PKC dependent.
Netrins are important in axonal guidance, regulation and
maintenance of central nervous system and are also involved in the
development of mammary gland, lung, pancreas, and blood vessel
[23]. Even though there is some controversy, most recent studies
suggested that netrin-1 functions as a pro-angiogenic factor. In
vivo studies also indicated that netrins promoted neovasculariza-
tion and reperfusion in a murine model of peripheral vascular
disease and also induced migration, proliferation and tube
formation during in vitro studies involving multiple endothelial
cell lines [24]. Characterizing a mechanism for netrin-1 induced
angiogenesis, a critical role for NO has been elucidated subsequent
to feed-forward ERK1/2 and eNOS activation in endothelial cells
treated with netrin-1 [25]. Our results showed that netrin-1
expression increased significantly in
ShhMSCs both at the protein
and RNA levels in PKC (PKM) dependent fashion.
Another interesting finding in the present study was the
presence of PKM fragment of PKC in
ShhMSCs at 72-h after
transfection with Shh plasmid. PKM is a constitutively active 40-
kDa catalytic fragment of PKC [26]. The regulatory role of PKC
in Shh signaling has been reported previously [22]. In a study
involving NIH 3T3 cells, PKC-d was integral to hedgehog
signaling to promote proliferative activity of the cells [27]. In
our present study, treatment of
ShhMSCs with both the PKC
inhibitor chel and Shh inhibitor cyclopamine abolished PKM
fragment which indicated that PKM was downstream of Shh and
that PKC was essential for its upregulation. White et al. (2007)
while experimenting on intact sea urchin spermatozoa showed
PKC, most likely through its cleavage into active catalytic product
PKM, was the central signaling mediator associated with
maintenance of sperm mobility [26]. PKC inhibitors such as chel
and calphostin-C, as well as staurosporine, were found to rapidly
arrest the motility of sea urchin spermatozoa freshly released into
seawater. At the same time, these inhibitors prevented the motility-
associated increase in phosphorylation of several PKC substrates.
Pretreatment of
ShhMSCs with these inhibitors abrogated PKM
with concurrent abrogation of iNOS and netrin-1.
Figure 8.
ShhMSCs transplantation preserved global function of the infarcted heart. Echocardiographic assessment of the heart function
indices (LVEF and LVFS) showed that preservation of the global heart function at 8 weeks after their respective treatment was significantly better in
group-3 in comparison with DMEM injected group-1 and
EmpMSCs transplanted group-2. LVEF and LVFS were calculated 1-week after myocardial
infarction (before their respective treatment) and 8-weeks after respective treatment. Results are shown as mean6SEM (n=7 animal per group).
doi:10.1371/journal.pone.0008576.g008
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histological data was the improved survival of
ShhMSCs post
engraftment. In view of the reported data that massive loss of the
transplanted cells occurs after transplantation remains a major
determinant of the effectiveness of heart cell therapy,
ShhMSCs are
at an advantage in terms of their survival after engraftment.
Histological studies at eight weeks after cell transplantation showed
a marked reduction in infarct size and preservation of host
myocardium in
ShhMSCs transplanted group as compared with
EmpMSC and DMEM groups. The cytoprotective effects were
accompanied by a significant increase in capillary density and a
higher number of mature blood vessels (smooth muscle actin
positive cells) in
ShhMSCs group. These results are consistent with
earlier studies using direct injection of Shh plasmid into the
infarcted heart [4,6,24].
In conclusion
ShhMSCs showed upregulation of several
angiogenic cytokines and signaling molecules including Ang-1,
VEGF, IGF, HGF, iNOS and netrin-1. Additionally,
ShhMSCs
also generated NO at significantly higher levels. These molecular
changes were mediated by iNOS/netrin/PKC signaling pathway
downstream of Shh gene overexpression which combined with
stem cell transplantation could be a promising strategy for the
treatment of an infarcted heart.
Supporting Information
Text S1
Found at: doi:10.1371/journal.pone.0008576.s001 (0.06 MB
DOC)
Figure S1 Construction of Shh plasmid. (A) Vector Map used in
construction of Shh-plasmid. The vector backbone was purchased
from commercial source (Stratagene, USA) and Shh mRNA was
isolated from 14-day rat embryo, used for cDNA synthesis and
cloned into pCMV Script vector. (B) Sequence of pCMV Shh-
vector using T7 and T3 primers showing sequence of Shh gene
insert. (C) Flow cytometry for surface marker expression showed
that overexpression of Shh transgene did not alter the expression
of surface markers in
ShhMSCs (indicated by red line) including
CD44, CD59, CD105 and CD106 as compared with the Empty
vector transfected MSCs (
EMPMSCs; indicated by black line).
Found at: doi:10.1371/journal.pone.0008576.s002 (2.61 MB TIF)
Figure S2 Abrogation of PI3K in
ShhMSCs using PI3K specific
siRNA. Western blot showing successful abrogation of PI3K in
ShhMSCs following transfection with PI3K specific siRNA.
ShhMSCs transfected with scrambled siRNA (Sc siRNA) and
EmpMSCs with siRNA transfection were used as controls.
Successful abrogation of PI3K was indicated by loss of Akt
phosphorylation.
Found at: doi:10.1371/journal.pone.0008576.s003 (0.85 MB TIF)
Figure S3 Cytoprotective effects of conditioned medium from
ShhMSCs (
ShhCM) on native MSCs. LDH release assay showed
that
ShhCM was significantly more protective for native MSCs
against oxidant stress as compared with conditioned medium from
EmpMSCs (
EmpCM).
Found at: doi:10.1371/journal.pone.0008576.s004 (1.05 MB TIF)
Figure S4 Cytoprotective effects of conditioned medium from
ShhMSCs (
ShhCM) on native H2C9 cardiomyocytes. LDH release
assay showed that ShhCM was significantly more protective for




Found at: doi:10.1371/journal.pone.0008576.s005 (1.17 MB TIF)
Table S1 Primary antibodies used for Western immunoblotting
and immunohistochemistry.
Found at: doi:10.1371/journal.pone.0008576.s006 (0.03 MB
DOC)
Table S2 Primers used for classic and real-time PCR.
Found at: doi:10.1371/journal.pone.0008576.s007 (0.03 MB
DOC)
Table S3 Fold change in different growth factor and cytokine
expression in
ShhMSCs as compared with
EmpMSCs.
Found at: doi:10.1371/journal.pone.0008576.s008 (0.03 MB
DOC)
Table S4 The heart function indices measured by echocardiog-
raphy on (A) day-7 and (B) 8-weeks after cell transplantation.
Found at: doi:10.1371/journal.pone.0008576.s009 (0.03 MB
DOC)
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